Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ATRA compared with ZYME: revenue, margins and what each company keeps, and the suppliers and customers both name
ATRA
Atara Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ZYME
Zymeworks Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ATRA
Atara Biotherapeutics, Inc.
vs
ZYME
Zymeworks Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ATRA, solid
ZYME, dashed
ATRA
Atara Biotherapeutics, Inc.
Change
8.47
· pre 8.49
· delayed
Mkt cap
$80.4M
Revenue
$630,000
Q2 FY26
Revenue
$121M
FY25
ZYME
Zymeworks Inc.
Change
28.99
· pre 28.99
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$2.1B
Revenue
$5M
Q2 FY26
Revenue
$106M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
ATRA
Atara Biotherapeutics, Inc.
vs
ZYME
Zymeworks Inc.
8.47
pre 8.49
delayed
Price
28.99
pre 28.99
delayed
$80.4M
Mkt cap
$2.1B
Q2 FY26
$630,000
Revenue
$5M
Q2 FY26
FY25
$121M
Revenue
$106M
FY25
Change
Change
ATRA
8.47
vs
ZYME
28.99
Pre-market
Nov 2 '26
delayed